Xpan Inc. has received seed capital through the latest round of FACIT’s Prospects Oncology Fund. Xpan Inc., CEO Zaid Atto also won FACIT’s Falcons’ Fortunes pitch competition earlier this year, is developing expandable surgical ac …

Xpan Inc. has received seed capital through the latest round of FACIT’s Prospects Oncology Fund. Xpan Inc., CEO Zaid Atto also won FACIT’s Falcons’ Fortunes pitch competition earlier this year, is developing expandable surgical access ports that aim to increase safety and efficiency of minimally invasive surgeries. Read more here